Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation.
A new oral digoxin formulation, a digoxin-hydroquinone complex (99% dissolution at 5 min), was evaluated in 12 healthy human volunteers with reference to bioavailability and extent and time of peak serum digoxin levels. This preparation was compared with a commercial digoxin tablet (26% dissolution at 5 min), digoxin elixir, and a parenteral digoxin solution. Bioavailability was assessed by the 24-hr area under the serum digoxin-time curve and 48-hr digoxin excretion in urine. The bioavailability of the complex was similar to that of the elixir but not statistically different from that of the tablet. The tablet was less bioavailable than the elixir. There was less interindividual variation in bioavailability with the complex than with the elixir. Peak serum digoxin levels were higher with the complex than the tablet and were achieved more quickly.
D000284:Administration, Oral; D000328:Adult; D001682:Biological Availability; D004077:Digoxin / Q000008:administration & dosage / Q000378:metabolism*; D005260:Female; D006801:Humans; D006873:Hydroquinones / Q000378:metabolism; D007275:Injections, Intravenous; D008297:Male; D012995:Solubility; D012996:Solutions; D013607:Tablets; D013997:Time Factors
D006873:Hydroquinones; D012996:Solutions; D013607:Tablets; D004077:Digoxin